AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 106 min read$TH

Target Hospitality’s (NASDAQ:TH) Q2 CY2026: Strong Sales, Stock Jumps 10.6%

Target Hospitality (NASDAQ:TH) reported Q2 CY2026 revenue of $85.46 million, up 38.7% year on year and 7.8% above Wall Street estimates. Full-year revenue guidance midpoint is $415 million, 10.4% above analysts’ estimates. GAAP EPS was -$0.09, above consensus. Shares rose 10.6% to $18.26 after the release.

Original reporting
financialcontent.com
Published Aug 10, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 12:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Target Hospitality’s (NASDAQ:TH) Q2 CY2026: Strong Sales, Stock Jumps 10.6% — source image
Source · financialcontent.com
Decision brief

The 30-second read

$THBullishMed
01

Why it matters

Q2 revenue and full-year revenue guidance beat expectations, and EPS loss narrowed versus last year, driving a same-day rally. However, operating margin remains negative and the article flags ongoing profitability risk.

02

Market read

Traders can reassess near-term expectations based on the revenue/guidance beat, while monitoring whether margin improvement follows the top-line acceleration.

03

What to watch

Utilized beds have declined on average over the last two years, so traders may question whether the latest quarter’s growth is sustainable versus a temporary property mix or utilization rebound.

Relevance 8/10Novelty 7/10Timing: immediately after Q2 results, stock jumped 10.6% to $18.26

Background

Target Hospitality provides specialty workforce lodging accommodations and services, including mini-communities at industrial sites.

Company-level read

Ticker impact

$THBullishMedium confidence
Context

Target Hospitality reported Q2 CY2026 revenue of $85.46M (+38.7% YoY) and full-year revenue guidance of $415M midpoint, beating estimates.

Expected impact

Bullish bias for the next few sessions as traders digest the beat and guidance, tempered by continued losses and negative operating margin.

Evidence & confidence

The article provides concrete, time-sensitive datapoints (revenue beat, guidance beat, EPS loss narrowing) plus a same-day price move, but it also highlights persistent unprofitability (negative operating margin, negative EPS outlook).

Market effects

Sector

Workforce lodging demand and utilization metrics (utilized beds) appear to be improving, which can support sentiment for specialty lodging operators.

Regional

No specific regional demand drivers are provided in the article.

Global

Limited global spillover; the story is company-specific within a niche lodging segment.

Counterpoint

What could challenge this read

The revenue surge may not translate into durable profitability, given negative operating margin of -8.8% and a still-lossy earnings profile.

Key entities

  • company
    Target Hospitality

    Reported Q2 CY2026 results and full-year revenue guidance; stock rose 10.6% after the release.

Read at source← All news

Related articles

AUG 10
$THMedAI 8/10

Target Hospitality Announces Second Quarter 2026 Results Highlighting Strong Execution on Recent Contract Awards and Sustained Momentum on Strategic Growth Initiatives

Target Hospitality (NASDAQ: TH) reported Q2 2026 results for the quarter ended June 30, 2026. Revenue rose 39% to $85.5M, while it posted a net loss of $9.0M. Adjusted EBITDA increased to $18.2M. The company raised its 2026 revenue and adjusted EBITDA outlook by 11% and 13%, citing $1.4B in multi-year WHS contract awards and a new $660M ABL facility.

prnewswire.com6 min
AUG 10
$THMedAI 9/10

Target Hospitality Corp. (TH): Results of Operations and Financial Condition

Target Hospitality Corp. (TH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 th-20260810xex99d1.htm EX-99.1 ​ Exhibit 99.1 ​ Target Hospitality Announces Second Quarter 2026 Results Highlighting Strong Execution on Recent Contract Awards and Sustained Momentum on Strategic Growth Initiatives ​ Since January 2026, secured over $1.4 billion of mul

SEC EDGAR 8-K6 min
JUL 27
$THMed

Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth

Target Hospitality (NASDAQ: TH) said it closed a new $660 million asset-based revolving credit facility, replacing a prior $175 million revolver. The five-year ABL matures in July 2031 and includes an accordion up to $190 million. Borrowings are priced at Term SOFR plus 2.25% to 3.00%, and the company expects up to a 250 bps cost-of-capital reduction.

prnewswire.com2 min
MAY 28
$THMedAI 9/10

Target Hospitality Announces Pricing of Secondary Offering

Target Hospitality Corp. priced a previously announced underwritten secondary offering of 7,000,000 shares of common stock at $17.00 per share, held by Arrow Holdings S.à r.l. and MFA Global S.à r.l., entities controlled by TDR Capital LLP. Gross proceeds to the selling stockholders total about $119 million; Target Hospitality will receive no proceeds. Closing is expected May 29, 2026, with a 30-day option for up to 1,050,000 additional shares.

prnewswire.com2 min
MAY 27
$THHighAI 9/10

Target Hospitality Announces Launch of Secondary Offering

Target Hospitality Corp. (Nasdaq: TH) announced an underwritten secondary offering of 7,000,000 shares of its common stock by selling stockholders Arrow Holdings S.à r.l. and MFA Global S.à r.l., entities controlled by TDR Capital LLP. The company will not receive proceeds. An option allows underwriters to buy up to 1,050,000 additional shares. Morgan Stanley and Deutsche Bank are book-running managers.

prnewswire.com2 min
AUG 10
$TBPHHigh

Theravance Biopharma, Inc. (TBPH): Results of Operations and Financial Condition

Theravance Biopharma, Inc. (TBPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622638d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update · Previously announced acquisition by Zymeworks expected to close in second half of 2026 · YUPELRI ® Collaboration Rev

SEC EDGAR 8-K6 min